Cleveland Clinic's Dr. Matt Kalaycio Appointed Chair of Board of Directors for National Comprehensive Cancer NetworkCancer Network
2024-04-08
高管变更
Dr. Christopher Lieu of the University of Colorado elected as incoming Vice-Chair for the alliance of leading cancer centers.
PLYMOUTH MEETING, Pa., April 8, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—a nonprofit devoted to patient care, research, and education—is announcing the election of
Matt Kalaycio, MD, FACP, as Chair of the Board of Directors, with
Christopher H. Lieu, MD, elected as Vice-Chair, succeeding Dr. Kalaycio in the position he has held since 2022.
来源: PRNewswire
NCCN elects Matt Kalaycio, MD, FACP, Vice-Chair of Cleveland Clinic Cancer Institute as Chair of the Board of Directors; Christopher H. Lieu, MD, Associate Director for Clinical Research for the University of Colorado Cancer CenterCancer Center, as Vice-Chair.
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
靶点
-药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。